Predictive value of ex-vivo drug-inhibited cytokine production for clinical response to biologic DMARD therapy in rheumatoid arthritis.
Clinical and experimental rheumatology
View this publicationClinical and experimental rheumatology
View this publicationScientific reports
View this publicationCell host & microbe
View this publicationThe oncologist
View this publication